trial · primary record
Recombinant Human Truncated Plasmin Injection (JZB32)
Vitreomacular Traction (VMT)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2028-05-30 |
| Primary endpoint | Percentage of study eyes with resolution of vitreomacular traction (VMT) assessed by OCT |
| Registry ID | NCT07910630 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:53.540Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07910630
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.